Seeking Alpha

St. Jude Medical (STJ +2.1%) ticks higher after being upgraded to Buy at Goldman. The firm cites...

St. Jude Medical (STJ +2.1%) ticks higher after being upgraded to Buy at Goldman. The firm cites share gains in its core markets and entrance into new therapeutic categories, which could accelerate revenue growth through 2015. It also raises its price target to $50 from $45.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)